Trem-1 and Ultraviolet Radiation-induced Immune Suppression
NCT05020496
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Skin Diseases
Interventions
DRUG:
Diphenylcyclopropenone (DPCP)
Sponsor
University of Alabama at Birmingham